Evidence map›Paper›PMID 28196537›Full record

ArticleBMC medical genetics2017

Characterization of a novel disease-causing mutation in exon 1 of SH2D1A gene through amplicon sequencing: a case report on HLH.

Shiyuan Zhou, Hongyu Ma, Bo Gao, Guangming Fang, Yi Zeng, Qing Zhang, GaoFu Qi

Abstract readCase Reports
In one paragraph

Article in BMC medical genetics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Shiyuan ZhouHenan Research Institute for Population and Family Planning, Zhengzhou, China.
Hongyu MaThermo Fisher Scientific, Building 6, N0.27, Xin Jinqiao Rd, Pudong, Shanghai, China.
Bo GaoDepartment of Laboratory Medicine, Taihe Hospital, Hubei University of Medicine, Shiyan, China.
Guangming FangDepartment of Clinical Medicine, Zhengzhou University, No.100 Science Avenue, Zhengzhou, China.
Yi ZengDepartment of Clinical Medicine, Zhengzhou University, No.100 Science Avenue, Zhengzhou, China.
Qing ZhangThermo Fisher Scientific, Building 6, N0.27, Xin Jinqiao Rd, Pudong, Shanghai, China. qing.zhang@thermofisher.com.
GaoFu QiInstitute of System Biology, Jianghan University, Sanjiaohu Rd, Wuhan, Hubei, China. fangzhiwei1126@126.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHemophagocytic lymphohistocytosis (HLH) is a rare but fatal hyperinflammatory syndrome caused by uncontrolled proliferation of activated macrophages and T lymphocytes secreting high amounts of inflammatory cytokines. Genetic defect is a common cause of HLH. HLH is complicated to be diagnosed as there are many common symptoms with other disorders. CASE PRESENTATION: Here we report on an HLH case caused by 1 bp deletion in gene SH2D1A. Patient was a 3-years-old boy and had fever for more than 8 days. Splenomegaly and hemophagocytosis in bone marrow were observed in examination. The results of the blood analysis suggested the diagnosis of HLH. Genetic test based on high throughput amplicon sequencing was then conducted by targeting all six known HLH-causing genes simultaneously. It took only one single day to accomplish the amplicon sequencing library preparation, sequencing and data analysis. Finally, a novel 1 bp deletion in gene SH2D1A was discovered. The result was also confirmed by Sanger sequencing. The result of the genetic test served as a good basis for further diagnosis of HLH.

conclusionThis is the first case that the disease-causing genetic defect of HLH was quickly determined by high throughput amplicon sequencing. This diagnosis was also confirmed by Sanger sequencing and cross-validated by blood analysis and other clinical criteria. This case suggests that genetic test based on amplicon sequencing is a powerful tool for diagnosis of HLH and other diseases caused by genetic defect.

Indexed as

Base SequenceBone MarrowChild, PreschoolDNAExonsGene DeletionGenetic TestingHumansLymphohistiocytosis, HemophagocyticMaleSequence Analysis, DNASignaling Lymphocytic Activation Molecule Associated ProteinDNASH2D1A protein, humanSignaling Lymphocytic Activation Molecule Associated ProteinAmplicon sequencingGenetic analysisHLHMutationSH2D1A

Identifiers

PMID28196537
PMCPMC5310059

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.